Increased Mortality in Diabetic Foot Ulcer Patients: The Significance of Ulcer Type

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Chammas, N K ^a   Hill, R L R ^b   Edmonds, M E ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA RUPTURE; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; BRONCHOPNEUMONIA; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DEATH CERTIFICATE; DIABETIC FOOT; DIABETIC PATIENT; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART INFARCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; SEPTICEMIA; THROMBOEMBOLISM; AGE; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HEART MUSCLE ISCHEMIA; ISCHEMIA; MIDDLE AGED; UNITED KINGDOM; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; UNITED KINGDOM;

EID: 84973299568     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/2879809     Document Type: Article

References (37)

1. E. J. Boyko, J. H. Ahroni, D. G. Smith, and D. Davignon, "Increased mortality associated with diabetic foot ulcer, " Diabetic Medicine, vol. 13, no. 11, pp. 967-972, 1996.
2. O. Nelzen, D. Bergqvist, and A. Lindhagen, "Long-term prognosis for patients with chronic leg ulcers: A prospective cohort study, " European Journal of Vascular and Endovascular Surgery, vol. 13, no. 5, pp. 500-508, 1997.
3. J. P. Challeton, M. Letanoux, J. P. Melki, J. J. Mourad, and P. Priollet, "Le pied diabétique: pronostic dans une série de 75 patients, " La Revue de Médecine Interne, vol. 14, no. 10, p. 1036, 1993.
4. T. W. Klamer, J. B. Towne, D. F. Bandyk, and M. J. Bonner, "The influence of sepsis and ischaemia on the natural history of the diabetic foot, " The American Surgeon, vol. 53, pp. 490-494, 1987.
5. P. K. Moulik, R. Mtonga, andG. V. Gill, "Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology, " Diabetes Care, vol. 26, no. 2, pp. 491-494, 2003.
6. M. M. Iversen, G. S. Tell, T. Riise et al., "History of foot ulcer increases mortality among individuals with diabetes: tenyear follow-up of the Nord-Trøndelag health study, Norway, " Diabetes Care, vol. 32, no. 12, pp. 2193-2199, 2009.
7. N. K. Chammas, R. L. R. Hill, A. V. M. Foster, and M. E. Edmonds, "Is neuropathic ulceration the key to understanding increased mortality due to ischaemic heart disease in diabetic foot ulcer patients? A population approach using a proportionatemodel, " Journal of InternationalMedical Research, vol. 30, no. 6, pp. 553-559, 2002.
8. M. E. Edmonds, M. P. Blundell, M. E. Morris, E. M. Thomas, L. T. Cotton, and P. J. Watkins, "Improved survival of the diabetic foot: the role of a specialised foot clinic, " Quarterly Journal of Medicine, vol. 60, no. 232, pp. 763-771, 1986.
9. I. Mühlhauser, P. Sawicki, M. Blank, H. Overmann, B. Richter, and M. Berger, "Reliability of causes of death in persons with type I diabetes, " Diabetologia, vol. 45, no. 11, pp. 1490-1497, 2002.
10. C. Hansson, E. Andersson, andG. Swanbeck, "Afollow-up study of leg and foot ulcer patients, " Acta Dermato-Venereologica, vol. 67, no. 6, pp. 496-500, 1987.
11. J. R. W. Brownrigg, J. Davey, P. J. Holt et al., "The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: A meta-analysis, " Diabetologia, vol. 55, no. 11, pp. 2906-2912, 2012.
12. D. Martins-Mendes, M. Monteiro-Soares, E. J. Boyko et al., "The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk, " Journal of Diabetes and its Complications, vol. 28, no. 5, pp. 632-638, 2014.
13. J. Van Baal, R. Hubbard, F. Game, and W. Jeffcoate, "Mortality associated with acute charcot foot and neuropathic foot ulceration, " Diabetes Care, vol. 33, no. 5, pp. 1086-1089, 2010.
14. M. J. Young, J. L. Breddy, A. Veves, and A. J. M. Boulton, "The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: A prospective study, " Diabetes Care, vol. 17, no. 6, pp. 557-560, 1994.
15. J. Elliott, S. Tesfaye, N. Chaturvedi et al., "EURODIAB prospective complications study group, " Diabetes Care, vol. 32, no. 10, pp. 1896-1900, 2009.
16. C. Weng, D. V. Coppini, N. Mozzakka, and P. H. Sönkson, "Deaths related to diabetic foot problems as an estimate of mortality associated with peripheral neuropathy, " DiabeticMedicine, vol. 13, supplement 7, article 79, 1996.
17. D. V. Coppini, P. A. Bowtell, C. Weng, P. J. Young, and P. H. Sönksen, "Showing neuropathy is related to increasedmortality in diabetic patients-a survival analysis using an accelerated failure timemodel, " Journal of Clinical Epidemiology, vol. 53, no. 5, pp. 519-523, 2000.
18. D.-J. Ewing, I.-W. Campbell, and B. F. Clarke, "Mortality in diabetic autonomic neuropathy, " The Lancet, vol. 307, no. 7960, pp. 601-603, 1976.
19. J. E. Gilmore, J. A. Allen, and J. R. Hayes, "Autonomic function in neuropathic diabetic patients with foot ulceration, " Diabetes Care, vol. 16, no. 1, pp. 61-67, 1993.
20. M. F. Di Carli, D. Bianco-Batlles, M. E. Landa et al., "Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus, " Circulation, vol. 100, no. 8, pp. 813-819, 1999.
21. R. Scognamiglio, A. Avogaro, D. Casara et al., "Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus, " Journal of the American College of Cardiology, vol. 31, no. 2, pp. 404-412, 1998.
22. J. J. O'Sullivan, R. M. Conroy, K. MacDonald, T. J. McKenna, and B. J. Maurer, "Silent ischaemia in diabetic men with autonomic neuropathy, " British Heart Journal, vol. 66, no. 4, pp. 313-315, 1991.
23. W. Jeffcoate, "Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?" Diabetologia, vol. 47, no. 9, pp. 1488-1492, 2004.
24. A. Ndip, F. L. Wilkinson, E. B. Jude, A. J. M. Boulton, and M. Y. Alexander, "RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy, " Diabetologia, vol. 57, no. 11, pp. 2251-2260, 2014.
25. F. Guerrero-Romero and M. Rodríguez-Morán, "Relationship of microalbuminuria with the diabetic foot ulcers in type II diabetes, " Journal of Diabetes and its Complications, vol. 12, no. 4, pp. 193-196, 1998.
26. M. O. Beck, S. P. Silveiro, R. Friedman, N. Clausell, and J. L. Gross, "Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients, " Diabetes Care, vol. 22, no. 10, pp. 1745-1747, 1999.
27. A. S. Astrup, L. Tarnow, P. Rossing, B. V. Hansen, J. Hilsted, and H.-H. Parving, "Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy, " Diabetes Care, vol. 29, no. 2, pp. 334-339, 2006.
28. L. A. Lavery, N. A. Hunt, A. Ndip, D. C. Lavery, W. VanHoutum, and A. J. M. Boulton, "Impact of chronic kidney disease on survival after amputation in individuals with diabetes, " Diabetes Care, vol. 33, no. 11, pp. 2365-2369, 2010.
29. I. Mantey, R. L. Hill, A. V. Foster, S. Wilson, J. J. Wade, and M. E. Edmonds, "Infection of foot ulcers with Staphylococcus aureus associated with increasedmortality in diabetic patients, " Communicable Disease and Public Health, vol. 3, no. 4, pp. 288-290, 2000.
30. V. A. Pavlov and K. J. Tracey, "Controlling inflammation: the cholinergic anti-inflammatory pathway, " Biochemical Society Transactions, vol. 34, no. 6, pp. 1037-1040, 2006.
31. T. R. Bernik, S. G. Friedman, M. Ochani et al., "Cholinergic anti-inflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion, " Journal of Vascular Surgery, vol. 36, no. 6, pp. 1231-1236, 2002.
32. C. J. Czura, S. G. Friedman, and K. J. Tracey, "Neural inhibition of inflammation: the cholinergic anti-inflammatory pathway, " Journal of Endotoxin Research, vol. 9, no. 6, pp. 409-413, 2003.
33. A. I. Adler, E. J. Boyko, J. H. Ahroni, V. Stensel, R. C. Forsberg, and D. G. Smith, "Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study, " Diabetes Care, vol. 20, no. 7, pp. 1162-1167, 1997.
34. N. A. Roper, R. W. Bilous, W. F. Kelly, N. C. Unwin, and V. M. Connolly, "Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study, " British Medical Journal, vol. 322, no. 7299, pp. 1389-1393, 2001.
35. K. Fagher and M. Löndahl, "The impact of metabolic control and QTc prolongation on all-cause mortality in patients with type 2 diabetes and foot ulcers, " Diabetologia, vol. 56, no. 5, pp. 1140-1147, 2013.
36. S. Morbach, H. Furchert, U. Gröblinghoff et al., "Long-term prognosis of diabetic foot patients and their limbs: Amputation and death over the course of a decade, " Diabetes Care, vol. 35, no. 10, pp. 2021-2027, 2012.
37. M. J. Young, J. E. McCardle, L. E. Randall, and J. I. Barclay, "Improved survival of diabetic foot ulcer patients 1995-2008, " Diabetes Care, vol. 31, pp. 2143-2147, 2008.